反应 #955931

ord-934f343f9c574c649df3333a64ecd535

反应方程式

Br.BrCc1ccccn1
2-(bromomethyl)pyridine hydrobromide
Cc1ccc(-c2nnc(N)o2)c(C)c1
5-(2,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine
O=C([O-])[O-].[K+].[K+]
K2CO3
Cc1ccc(-c2nnc(NCc3ccccn3)o2)c(C)c1
5-(2,4-Dimethylphenyl)-N-(pyridin-2-ylmethyl)-1,3,4-oxadiazol-2-amine
收率 97.0%

反应条件

温度
90°CELSIUS
详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他The solvent was removed under vacuum
  2. 2
    workup.DISSOLUTIONthe solid was dissolved in EtOAc
  3. 3
    洗涤washed successively with aq. NaHCO3 and brine
  4. 4
    干燥dried over MgSO4
  5. 5
    过滤filtered
  6. 6
    其他evaporated
  7. 7
    其他The residue was purified on silica gel

实验过程

To a solution of 5-(2,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine (Example 16a) (94.5 mg, 0.5 mmol) in 5 ml of dry acetonitrile was added K2CO3 (207 mg, 1.5 mmol). To the suspension was added 2-(bromomethyl)pyridine hydrobromide (127 mg, 0.5 mmol) and the mixture was stirred at 90° C. overnight. The solvent was removed under vacuum and the solid was dissolved in EtOAc, washed successively with aq. NaHCO3 and brine, dried over MgSO4 filtered and evaporated. The residue was purified on silica gel to give 5-(2,4-Dimethylphenyl)-N-(pyridin-2-ylmethyl)-1,3,4-oxadiazol-2-amine (136 mg, 97%) as a white solid. 1H NMR (300 MHz, CdCl3): δ 2.34 (s, 3H), 2.5 (s, 3H), 5.1 (s, 2H), 7.07-7.08 (m, 2H), 7.21-7.33 (m, 2H), 7.64-7.68 (m, 2H), 8.59-8.60 (d, 1H); MS (M+H, 281).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US08968708B2uspto-grants-2015_03